Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI    SAN   FR0000120578

SANOFI (SAN)

2385
Real-time Quote. Real-time Tradegate - 07/28 08:21:42 am
76.48 EUR   +0.66%
4d ago SANOFI : Merial Assigned Patent
4d ago SANOFI INDIA : Q2 NET INCREASES 12.3% TO Rs57.5 CRORE
5d ago GENZYME : Patent Issued for Synthesis of UDP-Glucose: N-Acylsphingosine Glu..
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

10/08/2012 | 01:44am US/Eastern
Recommend:
0

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.

MAIN FACTS:

- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at inti.landauro@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : SANOFI
Recommend :
0
React to this article
Latest news on SANOFI
4d ago SANOFI : Merial Assigned Patent
4d ago SANOFI INDIA : Q2 NET INCREASES 12.3% TO Rs57.5 CRORE
5d ago GENZYME : Patent Issued for Synthesis of UDP-Glucose: N-Acylsphingosine Glucosyl..
5d ago GENZYME : Exact Sciences Reports Second-Quarter 2014 Financial Results
5d ago GlycoMimetics Introduces Mark A. Goldberg, M.D. to Board of Directors
6d ago EXCLUSIVE - INDIA'S LUPIN, U.S. FIRM : sources
6d ago SANOFI : Information concerning the total number of voting rights and shares
6d ago India's Lupin, U.S. firms weigh bids for GSK's mature drugs -sources
6d ago SANOFI : Pasteur : Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-..
07/18 REGENERON PHARMACEUTICALS : and Sanofi Report Dupilumab Study Results
Advertisement
Chart
Duration : Period :
SANOFI Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
SANOFI : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF